ep 15: oral 11β-hsd1 inhibitor azd4017 improves wound healing & skin integrity in adults with t2dm
Published 2 years ago • 210 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
0:47
bo-112: enhancing immune-checkpoint inhibition in solid tumors
-
0:54
climb thal-111: exagamglogene autotemcel for patients with β-thalassemia
-
0:54
treatment de-escalation in premenopausal patients with hr /her2- breast cancer and micro-metastasis
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
2:22
myeloma xi trial: lenalidomide maintenance therapy for multiple myeloma
-
15:23
reverse your type 2 diabetes episode 3 i 15min live series
-
3:40
final analysis of the phase 4 exels trial in high-risk patients with essential thrombocythemia
-
1:22:51
whs session l: wound healing foundation - 3m award lecture
-
1:31:26
sph medicine medical grand rounds 25apr2019
-
2:23
update on phase ii study of mgta-145 plerixafor for stem cell mobilization in multiple myeloma
-
3:12
nivolumab for perioperative esophageal and gastroesophageal cancer: checkmate 577
-
7:41
metabolic surgery clinics - right patient, right treatment - case based discussion part 4
-
1:07
double oncogenic hits of 17p13(del) and 1q21(amp) in myeloma
-
1:56
medi5752: novel pd-1/ctla-4 bispecific checkpoint inhibitor for advanced solid tumors
-
51:02
medicine grand rounds 1-14-20
-
39:30
1st ese hypoparathyroidism patient forum–26 march 2022 session 2: current standards (eng)
-
1:21
vrd induction, mel200-conditioned autohsct and lenalidomide maintenance in multiple myeloma
-
2:50
diabetes health tips (dr hew)
-
1:12
remaining questions on the use of frontline cdk4/6 inhibitors endocrine therapy